Abstract
Diabetes is one of the highest leading causes of death in the United States with type 2 diabetes mellitus (DM2) being the most prevalent type. Despite many methods available for treatment, none have proven to be a curative option for patients diagnosed with diabetes mellitus. Recently, the use of surgical weight management has piqued interest with its ability to cause remission in DM2. This literature review compared the effects of Roux-en-Y gastric bypass (RYGB), laparoscopic gastric bypass, and pharmacotherapies alone. These methods showed improved outcomes of the following: hemoglobin A1c, weight loss, low density lipoprotein (LDL) cholesterol, blood pressure, and ultimately remission of DM2. Moreover, surgical weight management has potential to become an adequate alternative for management and remission of DM2.
Included in
An Assessment of Surgical Weight Management Compared to Pharmacological Therapies for Treatment of Type 2 Diabetes
Diabetes is one of the highest leading causes of death in the United States with type 2 diabetes mellitus (DM2) being the most prevalent type. Despite many methods available for treatment, none have proven to be a curative option for patients diagnosed with diabetes mellitus. Recently, the use of surgical weight management has piqued interest with its ability to cause remission in DM2. This literature review compared the effects of Roux-en-Y gastric bypass (RYGB), laparoscopic gastric bypass, and pharmacotherapies alone. These methods showed improved outcomes of the following: hemoglobin A1c, weight loss, low density lipoprotein (LDL) cholesterol, blood pressure, and ultimately remission of DM2. Moreover, surgical weight management has potential to become an adequate alternative for management and remission of DM2.